
Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group, appeared on The Early Show on CBS this morning to discuss Vytorin. Check it out!
Previously described as a cholesterol-busting drug, Vytorin is now reported to have no advantage over a generic cholesterol medicine, according to a new study. On The Early Show, Wolfe said that the FDA has done “a miserable job stopping ads that misrepresent drugs.”

















